US Medtech Company Icarus Medical Secures $7.2 Million in Series A Funding
2026-06-18 16:27
Favorite

en.Wedoany.com Reported - Icarus Medical, a medical technology company headquartered in Charlottesville, Virginia, USA, has announced the completion of its Series A funding round, which initially targeted $5 million but was oversubscribed to $7.2 million. Icarus Medical specializes in the research and development of orthopedic bracing technology. The proceeds from this funding will be used to accelerate nationwide commercialization, product development, manufacturing expansion, clinical validation of existing devices, and personnel growth.

 

The Adonis joint distraction knee brace utilizes dynamic joint distraction technology to help reduce pressure within the knee joint for patients with unicompartmental osteoarthritis.

The primary investors participating in this round include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners, and BLU Venture Investors. These investors will provide Icarus Medical with strategic medical, commercialization, operational expertise, and industry relationships.

Dave Johnson, Founder and CEO of Icarus Medical, stated that this funding validates the clinical impact of the company's technology and the strength of its team. The investors not only believe in the company's mission but also bring strategic insights and relationship networks that help accelerate its growth trajectory. The company is developing novel orthopedic bracing technology that combines biomechanics, additive manufacturing, and patient-centered design. Products include the Ascender knee brace for patellofemoral and multi-compartmental osteoarthritis, as well as solutions for post-surgical recovery, neurological conditions, and complex lower extremity mobility challenges.

Ben Spektor, Director of Venture Investments at OSF Ventures, noted that through discussions with clinicians, they validated that Icarus's solutions tangibly improve patients' lives and confirmed a significant unmet need, as well as the value of Icarus's innovative bracing technology. Spektor pointed out that Icarus is at the forefront of bracing innovation, and OSF Ventures supports its growth and helps expand the accessibility of this product within healthcare systems.

Icarus Medical designs and manufactures its products in Charlottesville. Over the past year, after achieving 1,283% three-year growth, the company was named to the Inc. 5000 list of America's fastest-growing private companies. The company also received the 2026 CBIC Startup of the Year Award from the Charlottesville Business Innovation Council.

Dave Johnson stated that healthcare innovation requires technology, clinical alignment, operational execution, and the ability to scale, and he believes this group of investors will enable the company to enter its next phase.

Icarus Medical is a medical technology company headquartered in Charlottesville, Virginia, focused on developing innovative orthopedic bracing solutions that help patients stay active, improve mobility, and reduce pain. The company combines biomechanics, software, and additive manufacturing to create advanced orthopedic technologies for osteoarthritis, post-surgical recovery, neurological conditions, and lower extremity mobility challenges.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com